1. Home
  2. AENT vs LCTX Comparison

AENT vs LCTX Comparison

Compare AENT & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

HOLD

Current Price

$7.10

Market Cap

392.4M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.71

Market Cap

366.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AENT
LCTX
Founded
1990
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.4M
366.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AENT
LCTX
Price
$7.10
$1.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$4.67
AVG Volume (30 Days)
61.0K
1.1M
Earning Date
02-12-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
131.70
N/A
EPS
0.38
N/A
Revenue
$1,088,441,000.00
$10,816,000.00
Revenue This Year
$8.23
$6.32
Revenue Next Year
$2.26
$124.49
P/E Ratio
$16.49
N/A
Revenue Growth
N/A
24.05
52 Week Low
$2.21
$0.37
52 Week High
$8.80
$2.09

Technical Indicators

Market Signals
Indicator
AENT
LCTX
Relative Strength Index (RSI) N/A 51.44
Support Level N/A $1.45
Resistance Level N/A $1.80
Average True Range (ATR) 0.00 0.09
MACD 0.00 0.01
Stochastic Oscillator 0.00 65.71

Price Performance

Historical Comparison
AENT
LCTX

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: